June 26, 2018
Saladax Signs Licensing Agreement with Janssen for Antipsychotic Drug Testing Patents
BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc., a diagnostics company providing kits to measure drug blood levels…
Read More March 21, 2018
Saladax Receives Approval to Sell a New Line of Psychiatry Tests on the European Market
Saladax is Advancing Personalized Medicine by Providing Doctors with Tests for Drug Levels to Better…
Read More October 14, 2017
Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel
Saladax Biomedical, Inc., recently presented a study on the value of adjusting paclitaxel doses. The…
Read More January 18, 2017
Saladax Licenses Alzheimer’s Diagnostic Tests to Siemens Healthineers
Tests can lead to early identification of Alzheimer’s Disease Bethlehem, PA--(BUSINESS WIRE)--January 18, 2017-- Saladax…
Read More October 28, 2016
Salvatore J. Salamone, Ph.D., Founder and CEO of Saladax Biomedical, Inc. Inducted into the New Jersey Inventors Hall of Fame
Saladax Biomedical, Inc., the leader in developing oncology diagnostics that increase the impact of personalized…
Read More October 19, 2016
Study Shows That Therapeutic Drug Monitoring Can Reduce Paclitaxel-Associated Neuropathy
Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic tests, today announced…
Read More June 9, 2015
Saladax Biomedical, Inc. Announces Presentation of CEPAC-TDM Study of Paclitaxel in Non-Small Cell Lung Cancer at 2015 ASCO Meeting
Large Study Confirms the Benefit to Patients of Advanced Dosing Method for Saladax Biomedical, Inc.…
Read More June 8, 2015
Saladax Biomedical, Inc. Announces the Presentation of the CESAR Study Results for Pharmacokinetically-Guided Dosing of 5-Fluorouracil in Colorectal Cancer at 2015 ASCO Meeting
Advantages of a Practical Approach to Personalized Dosing of 5-FU Demonstrated Saladax Biomedical, Inc. recently…
Read More December 1, 2014
Saladax Biomedical Announces U.S. Launch of MyImatinib™ Chemotherapy Exposure Optimization Test
Commercial Launch of MyImatinib™ Test Expands MyCare™ portfolio of Chemotherapy Exposure Optimization tests available from…
Read More July 23, 2014
Personalized Chemotherapy Tests Cleared for Use in China
Exposure Optimization Tests Fosun Diagnostics, a division of Fosun Pharmaceuticals, and Saladax Biomedical, Inc. today…
Read More